Atlas Trials

Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis

Clinical trial NCT04227314 · RECRUITING

Trial details

NCT number
NCT04227314
Sponsor
University Hospital, Rouen
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent Aphtous Stomatitis
Start date
2022-04-10
Primary completion
2026-12-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.